The Global Mass Spectrometer Market is likely to expand at a CAGR of 7.8% between 2019 and 2026. Fortune Business Insights in a report, titled “MASS SPECTROMETER: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts that the adoption of mass spectrometer equipment is likely to increase as this equipment can precisely measure the molecular weight of an analyst. The mass spectrometer instrument together with chromatography calculates the analytical mass of a particular molecule. The report predicts the Global Mass Spectrometer Market was valued at US$ 5,512.2 Mn in the year 2018 and is anticipated to reach US$ 10,044.7 Mn by 2026.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/mass-spectrometer-market-101068

Mass Spectrometer to Offer High-Resolution Analytical Data Owing to Technological Advancements

“Increasing research and development (R&D) activities are likely to increase the dependency on accurate and high-resolution data experiments,” said a lead analyst at Fortune Business Insights. “Mass spectrometer detectors have the ability to offer precise results, which is why key players encourage customers to opt for this equipment,” he added. Another factor driving the market is the increasing number of concerns related to food safety.

Owing to recent technological advancements in mass spectrometry, the demand from biotechnology and pharmaceutical industries is expected to increase. These advancements now offer better and high-resolution test results. The rising demand for tandem and hyphenated techniques, especially from biotechnology, food and beverages, and pharmaceutical industry is driving the market. The mass spectrometer miniaturization leads to the higher adoption of mass spectrometer equipment. All the above-mentioned factors are likely to be beneficial for the growth of the market

are some of the leading players in the global mass spectrometer market. Of these, companies such as SCIEX, Shimadzu, Waters, and Agilent are leading the market owing to their well-recognized brand presence. In addition to this, a robust distribution networking channel is another factor behind the success of these four players. Several companies are involved in strategic decisions to expand their market share. One of them is associated with new product launches. Some of the product launches are mentioned below:

The Global Nurse Call Systems Market is anticipated to showcase notable growth owing to the reduction in the number of patient to nurse ratio. According to a report by Fortune Business Insights, titled, “Nurse Call Systems Market Size, Share & Industry Analysis, By Technology (Wired, Wireless), By Product (Basic Button Based Systems, Mobile Integrated Systems, IP Based Systems, Others), By End-user (Hospitals and Clinics, Assisted Living and Nursing Centres, Home Care Setting, Others), and Regional Forecast, 2019-2026,” the global nurse call systems market size was valued at USD 1.18 Billion in 2018. However, the global market is projected to reach USD 2.78 Billion by 2026, exhibiting a CAGR of 11.4% during the forecast period.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/nurse-call-systems-market-100274

 Increasing Incidence of Chronic Disorders to Aid in the Growth of Hospital Segment

In terms of end user, the global nurse call systems market is grouped into home care settings, assisted living and nursing centers, hospitals and clinics, and others. The report mentions that hospitals are expected to generate the highest global nurse call systems market revenue in the forthcoming years. It would occur as the nurses in hospitals depend upon nurse call systems for workforce management, emergency management, and monitoring of patients’ health. Also, hospitals possess high patient pool who are in persistent need for general healthcare. Additionally, the rising prevalence of chronic diseases are leading to hospitalizations. It will contribute to the global nurse call systems market growth in the coming years.

The other healthcare facilities like a nursing home and assisted living centers are also estimated to experience considerable growth during the forecast period owing to the rising geriatric population combined with rising prevalence of neurological disorders in this patient population. In recent years there is a growing trend in elderly population preferring home care treatment. However, the home care setting in global nurse call system market held a lower market share.

The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes, blood pressure, and the wounds that result from them, such as diabetic foot ulcers and pressure ulcers. Wound care is used for injuries that are unable to heal by themselves. If untreated, they may result in severe consequences, such as mobility issues, decreased elasticity of blood vessels, and others. A recent report by Fortune Business Insights offers an elaborative overview of the market.

Please visit: https://www.fortunebusinessinsights.com/wound-care-market-103268

The report is titled, “Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027.” According to this report, the market value stood at USD 15.68 billion in 2019 and is likely to exhibit a CAGR of 6.0% between 2020 to 2027.

The worldwide pandemic of COVID-19 has shaken the world economy. Most businesses are at a halt, import-export is not possible, and the entire world is hoping to come out of this situation. With government support and necessary measures, we soon hope to overcome this situation and step into a better tomorrow. We, at Fortune Business Insights, are offering special reports on various markets impacted by the coronavirus pandemic and its future objectives. These reports will help investors study the market thoroughly and accordingly chalk out business strategies for generating future revenues.

North America is Holding Dominance on Account of Well-established Healthcare Infrastructure

North America earned a revenue of USD 6.09 billion in 2019 and emerged dominant, followed by Europe. This is on account of the increasing prevalence of acute and chronic wounds. This coupled with the presence of well-established healthcare infrastructure and facilities, as well as favorable reimbursement policies by the governments of developed nations are likely to aid in the expansion of the regional market.

On the other side, the market in Asia Pacific is likely to exhibit rapid growth in the coming years on account of the increasing prevalence of acute and chronic diseases as a result of the rising patient population and improving healthcare and medical infrastructure

The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market. Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period. North America is expected to contribute significantly towards the growth of the revenue cycle management market.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275

Some of the major companies that are present in the Global Revenue Cycle Management Market are;

• Microsoft
• IBM
• Dell
• McKesson
• Experian
• Allscripts
• Athenahealth
• Greenway Health
• GeBBS Healthcare Solutions
• ZirMed, now part of Waystar
• Epic Systems Corporation
• General Electric Manufacturing Company Cerner Corporation

The rising adoption of RCM among end users and presence of well-established healthcare infrastructure is expected to drive the RCM market in North America. In addition to this, revenue cycle management solutions offer long-term benefits, which is a key reason behind its high uptake in the region. Furthermore, the increasing presence of physicians and hospitals in North America will fuel the demand for revenue cycle management services in the coming years.

According to studies, Asia Pacific is projected to exhibit a high growth in the global RCM market. The growth is primarily attributable to the rising target population looking for medical claims and treatment. Moreover, the market is expected to witness exceptional growth opportunities in India, China, Singapore, and Japan.

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026. The increasing investment in the R&D of newer products will have a massive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectable and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026.

Visit: https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521

Cosmeceuticals are products that are inclusive of normal cosmetics and a few pharmaceuticals. The primary purpose behind the use of these products is the need for enhancing body appearance. These functions are carried out by the antioxidants used in the cosmeceuticals products. Recent advances in manufacturing as well as ingredients of these products will bode well for the market in the forthcoming years.

The increasing adoption of visually appealing aesthetics, coupled with the availability of cosmeceuticals at a low cost, will have a positive impact on the growth of the market in the coming years. Additionally, the increasing number of regulatory approvals has boded well for the market in recent years and will continue to have a positive impact on the market in the coming years.

North America to Emerge Dominant; Increasing Investments by Major Companies Will Aid Market Growth

The report analyses the ongoing blood screening market trends across North America, Latin America, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific holds the highest market share, driven by the huge demand for these products in several countries across this region. As of 2018, the market in Asia Pacific was worth USD 18.32 billion and this value is projected to increase further in the coming years. Besides Asia Pacific, the market in North America and the Middle East and Africa will witness moderate growth in the coming years.

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027. Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656

Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease. The product is a protein that protects the body from necrotizing enterocolitis and is also used to reduce conditions such as diarrhea. The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections. The substance is found in human milk like colostrum, the first milk produced after the baby is born. Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world. The massive investments in research and development of the product associated with its effects on human health will bode well for the growth of the overall market in the coming years.

Despite Several Barriers, Covid-19 Pandemic to Present Several Growth Opportunities

The recent coronavirus outbreak has created a sense of panic across the world. As the Covid-19 cases continue to rise, governments of several countries across the world are taking strict measures to curb the spread of the disease. Although this has had a negative impact on several businesses, the bovine lactoferrin market is likely to derive growth from this situation. Recent market studies have indicated that bovine lactoferrin can also be used in the fight against coronavirus; a factor that is pivotal to the growth of the market. As a result, the Covid-19 pandemic will have a positive impact on market growth.

The global E-prescribing market size is projected to reach USD 4,017.79 million by 2026 owing to the implementation of e-prescribing software in the electronic health record solutions that simplified prescription filling over the years. E-prescribing or electronic prescribing is a technology substructure that allows physicians and medical practitioners to send computer-based electronically generated prescriptions to a hospital-based or standalone pharmacy.

For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/e-prescribing-market-102698

It is also cost-efficient and reduces the chances of medication errors by pharmacists. The market is discussed in details in a recently published report by Fortune Business Insights™ titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician’s offices, Pharmacies) and Regional Forecast, 2019-2026.” As per this report, the market value was USD 863.64 million in 2018 and is expected to rise at a CAGR of 21.0 % in the forecast duration set between 2019 to 2026.

What are the Report Highlights?

The report is based on an in-depth analysis of the market and provides a 360-degree overview of the same. It throws light on significant industry developments, current e-prescribing market trends, and other interesting insights into the market. It discusses factors boosting, repelling, challenging, ad creating opportunities for the market during the forecast period. The report also describes the table of segmentation in detail and mentions the names and figures of the leading segments with their attributed factors. For more information on the report, log on to the company website.

North America Dominating Market with Increasing Digitization in Healthcare Sector

 Based on geographical segmentation, the market is dominated by North America, with a USD 399.61 million e-prescribing market share earned in 2018. Factors responsible for this dominance include the rise in digitalization in the healthcare sector and government-supported reimbursement policies with the flexible regulatory scenario. Additionally, the increasing funding from public and healthy private organizations with integrated adoption of EHR will help this region continue dominating the market in the coming years. On the other side, the market in Asia Pacific will witness exponential growth on account of the rising penetration of players in this region, especially in the emerging economies of China and India. Additionally, the increasing awareness about healthcare facilities and its associated benefits, coupled with the rising prevalence of chronic disorders, will help the market in the Middle East and Africa, witness stable growth.

Fortune Business Insights offers a detailed overview of the global market in a report, titled “Wearable Medical Devices Market” Size, Share and Industry Analysis by Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and, Regional Forecast 2019-2026.” As per the report, the market was valued at USD 24571.8 Million in 2018 and is anticipated to reach USD 139353.6 Million by 2026. The report offers a comprehensive overview of the market drivers, trends, opportunities, and other aspects of the market.

To Gain More Insights into the Market, Click Here: https://www.fortunebusinessinsights.com/industry-reports/wearable-medical-devices-market-101070

The global wearable medical devices market is anticipated to exhibit an exponential CAGR of 24.7% through the forecast years. The healthcare industry is revolutionizing owing to the rising adoption of connected devices. As digital technology is gaining immense popularity, wearable medical devices are evolving rapidly in the healthcare sector.

Moreover, the objective of these devices is to not only promote the overall body fitness but to offer active treatment regarding health conditions. From Fitbit to smartwatches, the market is increasingly driven by technological developments with focus on personalized care. Taking about personalized care, technologies such as internet of things (IoT), cloud computing, and others help in retrieving patient data in real-time, thereby allowing physicians to detect the patient’s health condition in advance.  

In addition to this, it provides valuable information on mergers and acquisitions, product launches, partnerships, and other strategic activities adopted by global players. Several estimations and projections for the leading geographies are also included in the report. All the above information can help our readers to gain valuable insights into the market, thereby helping them to make the right decision before investing in the market.    

The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. Furthermore, the increasing number of deaths caused by malaria has impelled government and pharmaceutical companies to develop advanced vaccines. According to the latest world malaria report, released in November 2018, there were 219 million cases of malaria in 2017, up from 217 million cases in 2016. The estimated number of malaria death stood at 435 000 in 2017, a similar number to the previous year.

According to the report, published by Fortune Business Insights in a report, titled “Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026” the market size stood at USD 41.61 billion in 2018.

The report offers profound insights into all the prevailing trends of the vaccine market. It delivers an all-encompassing synopsis of all the segments and provides analytical statistics for the same. It is put together after extensive research followed by deep analysis to benefit companies, stakeholders, financers and potential investors. It is designed with an aim to provide a clear picture of the market size. In addition, it also includes the latest advancement and development, product launches, acquisitions, collaborations & partnerships, and others.

The global foot orthotic insoles market size is expected to reach USD 4.50 billion by 2027. This is attributable to the rising geriatric population and the increasing incidence of diabetes that is driving the demand for advanced foot orthotic insoles globally. Fortune Business Insights, in its latest report, titled, “Foot Orthotic Insoles Market Size, Share & COVID-19 Impact Analysis, By Type (Prefabricated and Customized), By Application (Medical, Sports & Athletics, and Personal), By Material (Thermoplastics, Ethyl-vinyl Acetate (EVA), Foam, Composite Carbon Fibre, and Others), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital Pharmacies, Retail Stores, and Online Stores), and Regional Forecast, 2020-2027.”, observes that the market stood at USD 3.25 billion in 2019 and is likely to exhibit a CAGR of 6.1% between 2020 and 2027

For More Information: https://www.fortunebusinessinsights.com/industry-reports/foot-orthotic-insoles-market-100348

Suspension of Several Non-COVID-19 Healthcare Procedure to Impact Market Revenue

Due to cancellation or rescheduling of several outpatient appointments, the patient volume in orthotics and podiatry clinics has decreased significantly. This is owing to the growing shift towards treating COVID-19 patients on the advisory of the government agencies globally. This is likely to affect the revenue generation of the orthotic department. However, the growing adoption of digital technologies by the orthotic clinics is likely to favor the market growth in the forthcoming years.

What does the Report Provide?

The market report includes a qualitative and quantitative analysis of several factors such as the key drivers and restraints that will have an impact on the market. Furthermore, the report includes significant insights into the regional insights that include different regions, which are contributing to the market growth between 2020 and 2027. It includes the competitive landscape involving the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, collaborate, and acquire other companies that will contribute to the market growth.

Moreover, the research analyst has adopted several research methodologies such as PESTEL analysis to obtain information about the current trends and industry developments that will drive the market growth in the forthcoming years.